Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Controlled, Randomized Study Comparing Escitalopram Combined With Scopolamine or Escitalopram in Patients With Major Depressive Disorder

NCT03131050 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT03131050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03131050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Controlled, Randomized Study Comparing Escitalopram Combined With Scopolamine or Escitalopram in Patients With Major Depressive Disorder
Lead sponsor
Capital Medical University
Phase
Phase 4
Overall status
Completed
Start date
March 15, 2017
Completion date
March 8, 2018
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder